9 Sep 2016 12:38
InnovaDerma PLC
("InnovaDerma" or the "Company")
VOLUNTARY SUSPENSION OF TRADING ON MARCHÉ LIBRE PARIS SEGMENT OF EURONEXT
At the request of InnovaDerma, trading on Marché Libre Paris segment of Euronext for the under-mentioned securities has been suspended from 7 September 2016 pending an application to delist its shares. The Company successfully listed its entire issued share capital consisting of 10,318,535 ordinary shares of €0.10 each (the "Ordinary Shares") on the standard segment of the Official List of the UK Listing Authority to trading on the Main Market for listed securities of the London Stock Exchange on 7 September 2016. Trading in the Company's Ordinary Shares will continue on the London Stock Exchange through this time.
For information and guidance, InnovaDerma's shareholders should refer to the Company's Frequently Asked Questions section of its website at www.innovaderma.com/investor-relations-faq/. A further update will be provided when appropriate.
Further enquiries
InnovaDerma Haris Chaudhry/Joe Bayer
|
+61 (0)3 9111 0071 |
Sole broker Hybridan LLP Claire Noyce/Niall Pearson
| +44 (0)203 764 2341 / 2343 |
Cardew Group Shan Shan Willenbrock David Roach Emma Ruttle
|
+44 (0)20 7930 0777 |
About InnovaDerma:
InnovaDerma PLC specialises in the research, manufacture and marketing of clinically proven products in hair loss, anti-ageing and beauty sectors. InnovaDerma has presence in the United Kingdom, Australia, New Zealand, Philippines, South Africa, Hong Kong and South Korea.
www.innovadermaplc.com